教員情報 - 松岡　克善

教育・研究業績データベース検索ページ

学位

刊行論文

プロフィール

職歴

研究課題・受託研究・科研費

（最終更新日：2026-08-05 07:20:18）

  マツオカ　カツヨシ   Matsuoka Katsuyoshi
  松岡　克善
   所属   東邦大学医学部医学科（佐倉病院）

職種教授

学位

博士（医学）

刊行論文

1.	原著	Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease. 2026/07
2.	原著	Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. 2026/05
3.	原著	Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study. 2026/04
4.	原著	Lifestyle restrictions are associated with impaired quality of life but not reduction in relapse in ulcerative colitis. 2026/04
5.	原著	Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a post hoc analysis of safety and effectiveness in older (≥65 years) and younger (<65 years) patients. 2026/04
6.	原著	Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study. 2026/01
7.	原著	Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn's disease in Japan in 2023. 2025/12
8.	原著	Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status. 2025/11/22
9.	原著	Predictive factors for primary nonresponse to biologics in ulcerative colitis: a prospective multicenter study. 2025/11/07
10.	原著	A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease. 2025/09/27
11.	原著	Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study). 2025/09/22
12.	原著	Post Hoc Analysis of Anxiety and Behavioral Changes in Japanese Patients With Inflammatory Bowel Disease due to the COVID-19 Pandemic: Relationship Between Municipal Population at the Place of Residence and Anxiety. 2025/07/14
13.	原著	Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database. 2025/04/25
14.	原著	Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data 2025/04/21
15.	原著	First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study. 2025/01/30
16.	原著	Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis. 2025/01/04
17.	原著	Persistence of advanced therapies in patients with inflammatory bowel disease: retrospective cohort study using a large healthcare claims database in Japan. 2025/01/02
18.	原著	Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study. 2024/11/28
19.	原著	Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme. 2024/11/04
20.	原著	Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study 2024/09
21.	原著	Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study 2024/07
22.	原著	Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing 2024/07
23.	原著	Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study 2024/06
24.	原著	Artificial intelligence quantifying endoscopic severity of ulcerative colitis in gradation scale 2024/05
25.	原著	Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies 2024/04
26.	原著	Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria 2024/04
27.	原著	Machine learning using clinical data at baseline predicts the medium-term efficacy of ustekinumab in patients with ulcerative colitis 2024/02
28.	原著	Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD). 2022/11
29.	原著	Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open. 2022/10
30.	原著	Certolizumab pegol for maintenance of medically induced remission in Crohn's disease. 2022/06
31.	原著	Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study. 2022/05
32.	原著	Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS). 2022/03
33.	原著	Physician-patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis. 2021/06/27
34.	総説	潰瘍性大腸炎におけるカルシニューリン阻害薬治療後の寛解維持治療としてのチオプリン製剤の有用性と限界 2020/03
35.	原著	Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study 2020/02
36.	原著	Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study. 2019/09
37.	原著	Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network). 2019/09
38.	原著	Predictors of mucosal healing during induction therapy in patients with acute moderate-to-severe ulcerative colitis. 2019/06
39.	原著	Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine. 2019/05
40.	総説	炎症性腸疾患の内科治療　抗TNF-α抗体製剤　ゴリムマブ 2019/05
41.	原著	Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy. 2018/12
42.	原著	Biologic treatment of Japanese patients with inflammatory bowel disease. 2018/11
43.	原著	Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative Colitis. 2018/11
44.	原著	Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease. 2018/10
45.	原著	Safety and efficacy of leukocytapheresis in elderly patients with ulcerative colitis: The impact in steroid-free elderly patients. 2018/08
46.	原著	Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study. 2018/07
47.	原著	Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. 2018/06
10件表示
全件表示(47件)

プロフィール

職歴

2018/04～

東邦大学医学部医学科（佐倉病院）教授

研究課題・受託研究・科研費

難治性炎症性腸管障害に関する調査研究